Literature DB >> 30026629

Effects of alfaxalone, thiopental, or propofol and diazepam on laryngeal motion in healthy dogs.

Barbara Ambros1, M Casey Gaunt1, Tanya Duke-Novakovski1, Susan M Taylor1.   

Abstract

Laryngeal function is assessed by direct visualization of the larynx under a light plane of anesthesia. This study compared the effects of 3 anesthetic protocols on arytenoid motion in healthy dogs. Eight dogs were randomly assigned to receive alfaxalone, propofol and diazepam, or thiopental. Videolaryngoscopy was performed and still images at maximum inspiration and expiration were used to measure the area and height of the glottal gap. The normalized glottal gap area (NGGA = area in pixels/height2) was calculated. The NGAA change was defined as the difference between NGAA during inspiration and exhalation. Data were analyzed using Mann-Whitney and Kruskal-Wallis tests, P-values < 0.05 were considered statistically significant. No significant difference among induction protocols was found when comparing NGGA change after induction or before recovery. Alfaxalone and propofol/diazepam are useful for evaluation of laryngeal function when administered to effect and a light plane of anesthesia is maintained.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30026629      PMCID: PMC6005073     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  12 in total

Review 1.  Diagnosing laryngeal paralysis.

Authors:  M M Smith
Journal:  J Am Anim Hosp Assoc       Date:  2000 Sep-Oct       Impact factor: 1.023

2.  Effects of intravenous diazepam or microdose medetomidine on propofol-induced sedation in dogs.

Authors:  Jeff C H Ko; Mark E Payton; Alison G White; David S Galloway; Tomohito Inoue
Journal:  J Am Anim Hosp Assoc       Date:  2006 Jan-Feb       Impact factor: 1.023

Review 3.  Laryngeal disease in dogs and cats.

Authors:  Catriona Macphail
Journal:  Vet Clin North Am Small Anim Pract       Date:  2014-01       Impact factor: 2.093

4.  Midazolam, as a co-induction agent, has propofol sparing effects but also decreases systolic blood pressure in healthy dogs.

Authors:  Amber Hopkins; Michelle Giuffrida; Maria Paula Larenza
Journal:  Vet Anaesth Analg       Date:  2013-10-07       Impact factor: 1.648

Review 5.  A review of laryngeal paralysis in dogs.

Authors:  H M Burbidge
Journal:  Br Vet J       Date:  1995 Jan-Feb

6.  Effects of thiopentone, propofol and alfaxalone on laryngeal motion during oral laryngoscopy in healthy dogs.

Authors:  Tesh M Smalle; Marthinus J Hartman; Lynette Bester; Roxanne K Buck; Geoffrey T Fosgate; Gareth E Zeiler
Journal:  Vet Anaesth Analg       Date:  2017-03-03       Impact factor: 1.648

7.  A comparison of thiopental, propofol, and diazepam-ketamine anesthesia for evaluation of laryngeal function in dogs premedicated with butorphanol-glycopyrrolate.

Authors:  Marjorie E Gross; John R Dodam; Eric R Pope; Brent D Jones
Journal:  J Am Anim Hosp Assoc       Date:  2002 Nov-Dec       Impact factor: 1.023

8.  A comparison of cardiopulmonary and anesthetic effects of an induction dose of alfaxalone or propofol in dogs.

Authors:  Jill K Maney; Molly K Shepard; Christina Braun; Jeannette Cremer; Erik H Hofmeister
Journal:  Vet Anaesth Analg       Date:  2013-01-19       Impact factor: 1.648

9.  Effect of three anesthetic induction protocols on laryngeal motion during laryngoscopy in normal cats.

Authors:  Pieter Nelissen; Federico Corletto; Francesco Aprea; Richard A S White
Journal:  Vet Surg       Date:  2012-08-22       Impact factor: 1.495

10.  Effects of various anesthetic agents on laryngeal motion during laryngoscopy in normal dogs.

Authors:  Aaron M Jackson; Karen Tobias; Cassie Long; Joseph Bartges; Ralph Harvey
Journal:  Vet Surg       Date:  2004 Mar-Apr       Impact factor: 1.495

View more
  1 in total

Review 1.  The Influence of Anaesthetic Drugs on the Laryngeal Motion in Dogs: A Systematic Review.

Authors:  Elisabeth Ranninger; Marta Kantyka; Rima Nadine Bektas
Journal:  Animals (Basel)       Date:  2020-03-22       Impact factor: 2.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.